2020-2025 Global Anti-Obesity Drugs Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
Anti-obesity drugs are the drugs that help in reducing or controlling body mass, either by decreasing the craving or increasing the consumption of calories. Appetite control is achieved through the use of agonists for appetite suppressing pathways.
This report elaborates the market size, market characteristics, and market growth of the Anti-Obesity Drugs industry, and breaks down according to the type, application, and consumption area of Anti-Obesity Drugs. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Anti-Obesity Drugs in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Anti-Obesity Drugs market covered in Chapter 13:
FlaxoSithKline plc
Norgine Pharmaceuticals Ltd.
Bristol-Myers Squibb
BoehringerIngelheim GmbH
Orexigen Therapeutics
Eisai Co, Ltd.
Takeda Pharmaceutical
Novo Nordisk
Alizyme
F. Hoffmann La Roche
Rhythm Pharmaceuticals
Vivus
Zafgen
GlaxoSmithKline
Pfizer
Shionogi USA
In Chapter 6, on the basis of types, the Anti-Obesity Drugs market from 2015 to 2025 is primarily split into:
Prescription Drugs
OTC Drugs
In Chapter 7, on the basis of applications, the Anti-Obesity Drugs market from 2015 to 2025 covers:
Men
Women
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
This report elaborates the market size, market characteristics, and market growth of the Anti-Obesity Drugs industry, and breaks down according to the type, application, and consumption area of Anti-Obesity Drugs. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Anti-Obesity Drugs in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Anti-Obesity Drugs market covered in Chapter 13:
FlaxoSithKline plc
Norgine Pharmaceuticals Ltd.
Bristol-Myers Squibb
BoehringerIngelheim GmbH
Orexigen Therapeutics
Eisai Co, Ltd.
Takeda Pharmaceutical
Novo Nordisk
Alizyme
F. Hoffmann La Roche
Rhythm Pharmaceuticals
Vivus
Zafgen
GlaxoSmithKline
Pfizer
Shionogi USA
In Chapter 6, on the basis of types, the Anti-Obesity Drugs market from 2015 to 2025 is primarily split into:
Prescription Drugs
OTC Drugs
In Chapter 7, on the basis of applications, the Anti-Obesity Drugs market from 2015 to 2025 covers:
Men
Women
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 ANTI-OBESITY DRUGS MARKET - RESEARCH SCOPE
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 ANTI-OBESITY DRUGS MARKET - RESEARCH METHODOLOGY
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 ANTI-OBESITY DRUGS MARKET FORCES
3.1 Global Anti-Obesity Drugs Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 ANTI-OBESITY DRUGS MARKET - BY GEOGRAPHY
4.1 Global Anti-Obesity Drugs Market Value and Market Share by Regions
4.1.1 Global Anti-Obesity Drugs Value ($) by Region (2015-2020)
4.1.2 Global Anti-Obesity Drugs Value Market Share by Regions (2015-2020)
4.2 Global Anti-Obesity Drugs Market Production and Market Share by Major Countries
4.2.1 Global Anti-Obesity Drugs Production by Major Countries (2015-2020)
4.2.2 Global Anti-Obesity Drugs Production Market Share by Major Countries (2015-2020)
4.3 Global Anti-Obesity Drugs Market Consumption and Market Share by Regions
4.3.1 Global Anti-Obesity Drugs Consumption by Regions (2015-2020)
4.3.2 Global Anti-Obesity Drugs Consumption Market Share by Regions (2015-2020)
5 ANTI-OBESITY DRUGS MARKET - BY TRADE STATISTICS
5.1 Global Anti-Obesity Drugs Export and Import
5.2 United States Anti-Obesity Drugs Export and Import (2015-2020)
5.3 Europe Anti-Obesity Drugs Export and Import (2015-2020)
5.4 China Anti-Obesity Drugs Export and Import (2015-2020)
5.5 Japan Anti-Obesity Drugs Export and Import (2015-2020)
5.6 India Anti-Obesity Drugs Export and Import (2015-2020)
5.7 ...
6 ANTI-OBESITY DRUGS MARKET - BY TYPE
6.1 Global Anti-Obesity Drugs Production and Market Share by Types (2015-2020)
6.1.1 Global Anti-Obesity Drugs Production by Types (2015-2020)
6.1.2 Global Anti-Obesity Drugs Production Market Share by Types (2015-2020)
6.2 Global Anti-Obesity Drugs Value and Market Share by Types (2015-2020)
6.2.1 Global Anti-Obesity Drugs Value by Types (2015-2020)
6.2.2 Global Anti-Obesity Drugs Value Market Share by Types (2015-2020)
6.3 Global Anti-Obesity Drugs Production, Price and Growth Rate of Prescription Drugs (2015-2020)
6.4 Global Anti-Obesity Drugs Production, Price and Growth Rate of OTC Drugs (2015-2020)
7 ANTI-OBESITY DRUGS MARKET - BY APPLICATION
7.1 Global Anti-Obesity Drugs Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Anti-Obesity Drugs Consumption by Applications (2015-2020)
7.1.2 Global Anti-Obesity Drugs Consumption Market Share by Applications (2015-2020)
7.2 Global Anti-Obesity Drugs Consumption and Growth Rate of Men (2015-2020)
7.3 Global Anti-Obesity Drugs Consumption and Growth Rate of Women (2015-2020)
8 NORTH AMERICA ANTI-OBESITY DRUGS MARKET
8.1 North America Anti-Obesity Drugs Market Size
8.2 United States Anti-Obesity Drugs Market Size
8.3 Canada Anti-Obesity Drugs Market Size
8.4 Mexico Anti-Obesity Drugs Market Size
8.5 The Influence of COVID-19 on North America Market
9 EUROPE ANTI-OBESITY DRUGS MARKET ANALYSIS
9.1 Europe Anti-Obesity Drugs Market Size
9.2 Germany Anti-Obesity Drugs Market Size
9.3 United Kingdom Anti-Obesity Drugs Market Size
9.4 France Anti-Obesity Drugs Market Size
9.5 Italy Anti-Obesity Drugs Market Size
9.6 Spain Anti-Obesity Drugs Market Size
9.7 The Influence of COVID-19 on Europe Market
10 ASIA-PACIFIC ANTI-OBESITY DRUGS MARKET ANALYSIS
10.1 Asia-Pacific Anti-Obesity Drugs Market Size
10.2 China Anti-Obesity Drugs Market Size
10.3 Japan Anti-Obesity Drugs Market Size
10.4 South Korea Anti-Obesity Drugs Market Size
10.5 Southeast Asia Anti-Obesity Drugs Market Size
10.6 India Anti-Obesity Drugs Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 MIDDLE EAST AND AFRICA ANTI-OBESITY DRUGS MARKET ANALYSIS
11.1 Middle East and Africa Anti-Obesity Drugs Market Size
11.2 Saudi Arabia Anti-Obesity Drugs Market Size
11.3 UAE Anti-Obesity Drugs Market Size
11.4 South Africa Anti-Obesity Drugs Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 SOUTH AMERICA ANTI-OBESITY DRUGS MARKET ANALYSIS
12.1 South America Anti-Obesity Drugs Market Size
12.2 Brazil Anti-Obesity Drugs Market Size
12.3 The Influence of COVID-19 on South America Market
13 COMPANY PROFILES
13.1 FlaxoSithKline plc
13.1.1 FlaxoSithKline plc Basic Information
13.1.2 FlaxoSithKline plc Product Profiles, Application and Specification
13.1.3 FlaxoSithKline plc Anti-Obesity Drugs Market Performance (2015-2020)
13.2 Norgine Pharmaceuticals Ltd.
13.2.1 Norgine Pharmaceuticals Ltd. Basic Information
13.2.2 Norgine Pharmaceuticals Ltd. Product Profiles, Application and Specification
13.2.3 Norgine Pharmaceuticals Ltd. Anti-Obesity Drugs Market Performance (2015-2020)
13.3 Bristol-Myers Squibb
13.3.1 Bristol-Myers Squibb Basic Information
13.3.2 Bristol-Myers Squibb Product Profiles, Application and Specification
13.3.3 Bristol-Myers Squibb Anti-Obesity Drugs Market Performance (2015-2020)
13.4 BoehringerIngelheim GmbH
13.4.1 BoehringerIngelheim GmbH Basic Information
13.4.2 BoehringerIngelheim GmbH Product Profiles, Application and Specification
13.4.3 BoehringerIngelheim GmbH Anti-Obesity Drugs Market Performance (2015-2020)
13.5 Orexigen Therapeutics
13.5.1 Orexigen Therapeutics Basic Information
13.5.2 Orexigen Therapeutics Product Profiles, Application and Specification
13.5.3 Orexigen Therapeutics Anti-Obesity Drugs Market Performance (2015-2020)
13.6 Eisai Co, Ltd.
13.6.1 Eisai Co, Ltd. Basic Information
13.6.2 Eisai Co, Ltd. Product Profiles, Application and Specification
13.6.3 Eisai Co, Ltd. Anti-Obesity Drugs Market Performance (2015-2020)
13.7 Takeda Pharmaceutical
13.7.1 Takeda Pharmaceutical Basic Information
13.7.2 Takeda Pharmaceutical Product Profiles, Application and Specification
13.7.3 Takeda Pharmaceutical Anti-Obesity Drugs Market Performance (2015-2020)
13.8 Novo Nordisk
13.8.1 Novo Nordisk Basic Information
13.8.2 Novo Nordisk Product Profiles, Application and Specification
13.8.3 Novo Nordisk Anti-Obesity Drugs Market Performance (2015-2020)
13.9 Alizyme
13.9.1 Alizyme Basic Information
13.9.2 Alizyme Product Profiles, Application and Specification
13.9.3 Alizyme Anti-Obesity Drugs Market Performance (2015-2020)
13.10 F. Hoffmann La Roche
13.10.1 F. Hoffmann La Roche Basic Information
13.10.2 F. Hoffmann La Roche Product Profiles, Application and Specification
13.10.3 F. Hoffmann La Roche Anti-Obesity Drugs Market Performance (2015-2020)
13.11 Rhythm Pharmaceuticals
13.11.1 Rhythm Pharmaceuticals Basic Information
13.11.2 Rhythm Pharmaceuticals Product Profiles, Application and Specification
13.11.3 Rhythm Pharmaceuticals Anti-Obesity Drugs Market Performance (2015-2020)
13.12 Vivus
13.12.1 Vivus Basic Information
13.12.2 Vivus Product Profiles, Application and Specification
13.12.3 Vivus Anti-Obesity Drugs Market Performance (2015-2020)
13.13 Zafgen
13.13.1 Zafgen Basic Information
13.13.2 Zafgen Product Profiles, Application and Specification
13.13.3 Zafgen Anti-Obesity Drugs Market Performance (2015-2020)
13.14 GlaxoSmithKline
13.14.1 GlaxoSmithKline Basic Information
13.14.2 GlaxoSmithKline Product Profiles, Application and Specification
13.14.3 GlaxoSmithKline Anti-Obesity Drugs Market Performance (2015-2020)
13.15 Pfizer
13.15.1 Pfizer Basic Information
13.15.2 Pfizer Product Profiles, Application and Specification
13.15.3 Pfizer Anti-Obesity Drugs Market Performance (2015-2020)
13.16 Shionogi USA
13.16.1 Shionogi USA Basic Information
13.16.2 Shionogi USA Product Profiles, Application and Specification
13.16.3 Shionogi USA Anti-Obesity Drugs Market Performance (2015-2020)
14 MARKET FORECAST - BY REGIONS
14.1 North America Anti-Obesity Drugs Market Forecast (2020-2025)
14.2 Europe Anti-Obesity Drugs Market Forecast (2020-2025)
14.3 Asia-Pacific Anti-Obesity Drugs Market Forecast (2020-2025)
14.4 Middle East and Africa Anti-Obesity Drugs Market Forecast (2020-2025)
14.5 South America Anti-Obesity Drugs Market Forecast (2020-2025)
15 MARKET FORECAST - BY TYPE AND APPLICATIONS
15.1 Global Anti-Obesity Drugs Market Forecast by Types (2020-2025)
15.1.1 Global Anti-Obesity Drugs Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Anti-Obesity Drugs Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Anti-Obesity Drugs Market Forecast by Applications (2020-2025)
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 ANTI-OBESITY DRUGS MARKET - RESEARCH METHODOLOGY
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 ANTI-OBESITY DRUGS MARKET FORCES
3.1 Global Anti-Obesity Drugs Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 ANTI-OBESITY DRUGS MARKET - BY GEOGRAPHY
4.1 Global Anti-Obesity Drugs Market Value and Market Share by Regions
4.1.1 Global Anti-Obesity Drugs Value ($) by Region (2015-2020)
4.1.2 Global Anti-Obesity Drugs Value Market Share by Regions (2015-2020)
4.2 Global Anti-Obesity Drugs Market Production and Market Share by Major Countries
4.2.1 Global Anti-Obesity Drugs Production by Major Countries (2015-2020)
4.2.2 Global Anti-Obesity Drugs Production Market Share by Major Countries (2015-2020)
4.3 Global Anti-Obesity Drugs Market Consumption and Market Share by Regions
4.3.1 Global Anti-Obesity Drugs Consumption by Regions (2015-2020)
4.3.2 Global Anti-Obesity Drugs Consumption Market Share by Regions (2015-2020)
5 ANTI-OBESITY DRUGS MARKET - BY TRADE STATISTICS
5.1 Global Anti-Obesity Drugs Export and Import
5.2 United States Anti-Obesity Drugs Export and Import (2015-2020)
5.3 Europe Anti-Obesity Drugs Export and Import (2015-2020)
5.4 China Anti-Obesity Drugs Export and Import (2015-2020)
5.5 Japan Anti-Obesity Drugs Export and Import (2015-2020)
5.6 India Anti-Obesity Drugs Export and Import (2015-2020)
5.7 ...
6 ANTI-OBESITY DRUGS MARKET - BY TYPE
6.1 Global Anti-Obesity Drugs Production and Market Share by Types (2015-2020)
6.1.1 Global Anti-Obesity Drugs Production by Types (2015-2020)
6.1.2 Global Anti-Obesity Drugs Production Market Share by Types (2015-2020)
6.2 Global Anti-Obesity Drugs Value and Market Share by Types (2015-2020)
6.2.1 Global Anti-Obesity Drugs Value by Types (2015-2020)
6.2.2 Global Anti-Obesity Drugs Value Market Share by Types (2015-2020)
6.3 Global Anti-Obesity Drugs Production, Price and Growth Rate of Prescription Drugs (2015-2020)
6.4 Global Anti-Obesity Drugs Production, Price and Growth Rate of OTC Drugs (2015-2020)
7 ANTI-OBESITY DRUGS MARKET - BY APPLICATION
7.1 Global Anti-Obesity Drugs Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Anti-Obesity Drugs Consumption by Applications (2015-2020)
7.1.2 Global Anti-Obesity Drugs Consumption Market Share by Applications (2015-2020)
7.2 Global Anti-Obesity Drugs Consumption and Growth Rate of Men (2015-2020)
7.3 Global Anti-Obesity Drugs Consumption and Growth Rate of Women (2015-2020)
8 NORTH AMERICA ANTI-OBESITY DRUGS MARKET
8.1 North America Anti-Obesity Drugs Market Size
8.2 United States Anti-Obesity Drugs Market Size
8.3 Canada Anti-Obesity Drugs Market Size
8.4 Mexico Anti-Obesity Drugs Market Size
8.5 The Influence of COVID-19 on North America Market
9 EUROPE ANTI-OBESITY DRUGS MARKET ANALYSIS
9.1 Europe Anti-Obesity Drugs Market Size
9.2 Germany Anti-Obesity Drugs Market Size
9.3 United Kingdom Anti-Obesity Drugs Market Size
9.4 France Anti-Obesity Drugs Market Size
9.5 Italy Anti-Obesity Drugs Market Size
9.6 Spain Anti-Obesity Drugs Market Size
9.7 The Influence of COVID-19 on Europe Market
10 ASIA-PACIFIC ANTI-OBESITY DRUGS MARKET ANALYSIS
10.1 Asia-Pacific Anti-Obesity Drugs Market Size
10.2 China Anti-Obesity Drugs Market Size
10.3 Japan Anti-Obesity Drugs Market Size
10.4 South Korea Anti-Obesity Drugs Market Size
10.5 Southeast Asia Anti-Obesity Drugs Market Size
10.6 India Anti-Obesity Drugs Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 MIDDLE EAST AND AFRICA ANTI-OBESITY DRUGS MARKET ANALYSIS
11.1 Middle East and Africa Anti-Obesity Drugs Market Size
11.2 Saudi Arabia Anti-Obesity Drugs Market Size
11.3 UAE Anti-Obesity Drugs Market Size
11.4 South Africa Anti-Obesity Drugs Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 SOUTH AMERICA ANTI-OBESITY DRUGS MARKET ANALYSIS
12.1 South America Anti-Obesity Drugs Market Size
12.2 Brazil Anti-Obesity Drugs Market Size
12.3 The Influence of COVID-19 on South America Market
13 COMPANY PROFILES
13.1 FlaxoSithKline plc
13.1.1 FlaxoSithKline plc Basic Information
13.1.2 FlaxoSithKline plc Product Profiles, Application and Specification
13.1.3 FlaxoSithKline plc Anti-Obesity Drugs Market Performance (2015-2020)
13.2 Norgine Pharmaceuticals Ltd.
13.2.1 Norgine Pharmaceuticals Ltd. Basic Information
13.2.2 Norgine Pharmaceuticals Ltd. Product Profiles, Application and Specification
13.2.3 Norgine Pharmaceuticals Ltd. Anti-Obesity Drugs Market Performance (2015-2020)
13.3 Bristol-Myers Squibb
13.3.1 Bristol-Myers Squibb Basic Information
13.3.2 Bristol-Myers Squibb Product Profiles, Application and Specification
13.3.3 Bristol-Myers Squibb Anti-Obesity Drugs Market Performance (2015-2020)
13.4 BoehringerIngelheim GmbH
13.4.1 BoehringerIngelheim GmbH Basic Information
13.4.2 BoehringerIngelheim GmbH Product Profiles, Application and Specification
13.4.3 BoehringerIngelheim GmbH Anti-Obesity Drugs Market Performance (2015-2020)
13.5 Orexigen Therapeutics
13.5.1 Orexigen Therapeutics Basic Information
13.5.2 Orexigen Therapeutics Product Profiles, Application and Specification
13.5.3 Orexigen Therapeutics Anti-Obesity Drugs Market Performance (2015-2020)
13.6 Eisai Co, Ltd.
13.6.1 Eisai Co, Ltd. Basic Information
13.6.2 Eisai Co, Ltd. Product Profiles, Application and Specification
13.6.3 Eisai Co, Ltd. Anti-Obesity Drugs Market Performance (2015-2020)
13.7 Takeda Pharmaceutical
13.7.1 Takeda Pharmaceutical Basic Information
13.7.2 Takeda Pharmaceutical Product Profiles, Application and Specification
13.7.3 Takeda Pharmaceutical Anti-Obesity Drugs Market Performance (2015-2020)
13.8 Novo Nordisk
13.8.1 Novo Nordisk Basic Information
13.8.2 Novo Nordisk Product Profiles, Application and Specification
13.8.3 Novo Nordisk Anti-Obesity Drugs Market Performance (2015-2020)
13.9 Alizyme
13.9.1 Alizyme Basic Information
13.9.2 Alizyme Product Profiles, Application and Specification
13.9.3 Alizyme Anti-Obesity Drugs Market Performance (2015-2020)
13.10 F. Hoffmann La Roche
13.10.1 F. Hoffmann La Roche Basic Information
13.10.2 F. Hoffmann La Roche Product Profiles, Application and Specification
13.10.3 F. Hoffmann La Roche Anti-Obesity Drugs Market Performance (2015-2020)
13.11 Rhythm Pharmaceuticals
13.11.1 Rhythm Pharmaceuticals Basic Information
13.11.2 Rhythm Pharmaceuticals Product Profiles, Application and Specification
13.11.3 Rhythm Pharmaceuticals Anti-Obesity Drugs Market Performance (2015-2020)
13.12 Vivus
13.12.1 Vivus Basic Information
13.12.2 Vivus Product Profiles, Application and Specification
13.12.3 Vivus Anti-Obesity Drugs Market Performance (2015-2020)
13.13 Zafgen
13.13.1 Zafgen Basic Information
13.13.2 Zafgen Product Profiles, Application and Specification
13.13.3 Zafgen Anti-Obesity Drugs Market Performance (2015-2020)
13.14 GlaxoSmithKline
13.14.1 GlaxoSmithKline Basic Information
13.14.2 GlaxoSmithKline Product Profiles, Application and Specification
13.14.3 GlaxoSmithKline Anti-Obesity Drugs Market Performance (2015-2020)
13.15 Pfizer
13.15.1 Pfizer Basic Information
13.15.2 Pfizer Product Profiles, Application and Specification
13.15.3 Pfizer Anti-Obesity Drugs Market Performance (2015-2020)
13.16 Shionogi USA
13.16.1 Shionogi USA Basic Information
13.16.2 Shionogi USA Product Profiles, Application and Specification
13.16.3 Shionogi USA Anti-Obesity Drugs Market Performance (2015-2020)
14 MARKET FORECAST - BY REGIONS
14.1 North America Anti-Obesity Drugs Market Forecast (2020-2025)
14.2 Europe Anti-Obesity Drugs Market Forecast (2020-2025)
14.3 Asia-Pacific Anti-Obesity Drugs Market Forecast (2020-2025)
14.4 Middle East and Africa Anti-Obesity Drugs Market Forecast (2020-2025)
14.5 South America Anti-Obesity Drugs Market Forecast (2020-2025)
15 MARKET FORECAST - BY TYPE AND APPLICATIONS
15.1 Global Anti-Obesity Drugs Market Forecast by Types (2020-2025)
15.1.1 Global Anti-Obesity Drugs Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Anti-Obesity Drugs Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Anti-Obesity Drugs Market Forecast by Applications (2020-2025)
LIST OF TABLES AND FIGURES
Figure Anti-Obesity Drugs Picture
Table Anti-Obesity Drugs Key Market Segments
Figure Study and Forecasting Years
Figure Global Anti-Obesity Drugs Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Anti-Obesity Drugs Value ($) and Growth Rate (2015-2020)
Table Global Anti-Obesity Drugs Value ($) by Countries (2015-2020)
Table Global Anti-Obesity Drugs Value Market Share by Regions (2015-2020)
Figure Global Anti-Obesity Drugs Value Market Share by Regions in 2019
Figure Global Anti-Obesity Drugs Production and Growth Rate (2015-2020)
Table Global Anti-Obesity Drugs Production by Major Countries (2015-2020)
Table Global Anti-Obesity Drugs Production Market Share by Major Countries (2015-2020)
Figure Global Anti-Obesity Drugs Production Market Share by Regions in 2019
Figure Global Anti-Obesity Drugs Consumption and Growth Rate (2015-2020)
Table Global Anti-Obesity Drugs Consumption by Regions (2015-2020)
Table Global Anti-Obesity Drugs Consumption Market Share by Regions (2015-2020)
Figure Global Anti-Obesity Drugs Consumption Market Share by Regions in 2019
Table Global Anti-Obesity Drugs Export Top 3 Country 2019
Table Global Anti-Obesity Drugs Import Top 3 Country 2019
Table United States Anti-Obesity Drugs Export and Import (2015-2020)
Table Europe Anti-Obesity Drugs Export and Import (2015-2020)
Table China Anti-Obesity Drugs Export and Import (2015-2020)
Table Japan Anti-Obesity Drugs Export and Import (2015-2020)
Table India Anti-Obesity Drugs Export and Import (2015-2020)
Table Global Anti-Obesity Drugs Production by Types (2015-2020)
Table Global Anti-Obesity Drugs Production Market Share by Types (2015-2020)
Figure Global Anti-Obesity Drugs Production Share by Type (2015-2020)
Table Global Anti-Obesity Drugs Value by Types (2015-2020)
Table Global Anti-Obesity Drugs Value Market Share by Types (2015-2020)
Figure Global Anti-Obesity Drugs Value Share by Type (2015-2020)
Figure Global Prescription Drugs Production and Growth Rate (2015-2020)
Figure Global Prescription Drugs Price (2015-2020)
Figure Global OTC Drugs Production and Growth Rate (2015-2020)
Figure Global OTC Drugs Price (2015-2020)
Table Global Anti-Obesity Drugs Consumption by Applications (2015-2020)
Table Global Anti-Obesity Drugs Consumption Market Share by Applications (2015-2020)
Figure Global Anti-Obesity Drugs Consumption Share by Application (2015-2020)
Figure Global Men Consumption and Growth Rate (2015-2020)
Figure Global Women Consumption and Growth Rate (2015-2020)
Figure North America Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Table North America Anti-Obesity Drugs Consumption by Countries (2015-2020)
Table North America Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure North America Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure United States Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Canada Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Mexico Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Table Europe Anti-Obesity Drugs Consumption by Countries (2015-2020)
Table Europe Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure Europe Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure Germany Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure France Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Italy Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Spain Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Anti-Obesity Drugs Consumption by Countries (2015-2020)
Table Asia-Pacific Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure China Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Japan Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure South Korea Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure India Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Anti-Obesity Drugs Consumption by Countries (2015-2020)
Table Middle East and Africa Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure UAE Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure South Africa Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure South America Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Table South America Anti-Obesity Drugs Consumption by Countries (2015-2020)
Table South America Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure South America Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure Brazil Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Table FlaxoSithKline plc Company Profile
Table FlaxoSithKline plc Production, Value, Price, Gross Margin 2015-2020
Figure FlaxoSithKline plc Production and Growth Rate
Figure FlaxoSithKline plc Value ($) Market Share 2015-2020
Table Norgine Pharmaceuticals Ltd. Company Profile
Table Norgine Pharmaceuticals Ltd. Production, Value, Price, Gross Margin 2015-2020
Figure Norgine Pharmaceuticals Ltd. Production and Growth Rate
Figure Norgine Pharmaceuticals Ltd. Value ($) Market Share 2015-2020
Table Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Production, Value, Price, Gross Margin 2015-2020
Figure Bristol-Myers Squibb Production and Growth Rate
Figure Bristol-Myers Squibb Value ($) Market Share 2015-2020
Table BoehringerIngelheim GmbH Company Profile
Table BoehringerIngelheim GmbH Production, Value, Price, Gross Margin 2015-2020
Figure BoehringerIngelheim GmbH Production and Growth Rate
Figure BoehringerIngelheim GmbH Value ($) Market Share 2015-2020
Table Orexigen Therapeutics Company Profile
Table Orexigen Therapeutics Production, Value, Price, Gross Margin 2015-2020
Figure Orexigen Therapeutics Production and Growth Rate
Figure Orexigen Therapeutics Value ($) Market Share 2015-2020
Table Eisai Co, Ltd. Company Profile
Table Eisai Co, Ltd. Production, Value, Price, Gross Margin 2015-2020
Figure Eisai Co, Ltd. Production and Growth Rate
Figure Eisai Co, Ltd. Value ($) Market Share 2015-2020
Table Takeda Pharmaceutical Company Profile
Table Takeda Pharmaceutical Production, Value, Price, Gross Margin 2015-2020
Figure Takeda Pharmaceutical Production and Growth Rate
Figure Takeda Pharmaceutical Value ($) Market Share 2015-2020
Table Novo Nordisk Company Profile
Table Novo Nordisk Production, Value, Price, Gross Margin 2015-2020
Figure Novo Nordisk Production and Growth Rate
Figure Novo Nordisk Value ($) Market Share 2015-2020
Table Alizyme Company Profile
Table Alizyme Production, Value, Price, Gross Margin 2015-2020
Figure Alizyme Production and Growth Rate
Figure Alizyme Value ($) Market Share 2015-2020
Table F. Hoffmann La Roche Company Profile
Table F. Hoffmann La Roche Production, Value, Price, Gross Margin 2015-2020
Figure F. Hoffmann La Roche Production and Growth Rate
Figure F. Hoffmann La Roche Value ($) Market Share 2015-2020
Table Rhythm Pharmaceuticals Company Profile
Table Rhythm Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Figure Rhythm Pharmaceuticals Production and Growth Rate
Figure Rhythm Pharmaceuticals Value ($) Market Share 2015-2020
Table Vivus Company Profile
Table Vivus Production, Value, Price, Gross Margin 2015-2020
Figure Vivus Production and Growth Rate
Figure Vivus Value ($) Market Share 2015-2020
Table Zafgen Company Profile
Table Zafgen Production, Value, Price, Gross Margin 2015-2020
Figure Zafgen Production and Growth Rate
Figure Zafgen Value ($) Market Share 2015-2020
Table GlaxoSmithKline Company Profile
Table GlaxoSmithKline Production, Value, Price, Gross Margin 2015-2020
Figure GlaxoSmithKline Production and Growth Rate
Figure GlaxoSmithKline Value ($) Market Share 2015-2020
Table Pfizer Company Profile
Table Pfizer Production, Value, Price, Gross Margin 2015-2020
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2015-2020
Table Shionogi USA Company Profile
Table Shionogi USA Production, Value, Price, Gross Margin 2015-2020
Figure Shionogi USA Production and Growth Rate
Figure Shionogi USA Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Production by Types (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Production Share by Types (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Value ($) by Types (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Value Share by Types (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Consumption by Applications (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Consumption Share by Applications (2020-2025)
Figure Anti-Obesity Drugs Picture
Table Anti-Obesity Drugs Key Market Segments
Figure Study and Forecasting Years
Figure Global Anti-Obesity Drugs Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Anti-Obesity Drugs Value ($) and Growth Rate (2015-2020)
Table Global Anti-Obesity Drugs Value ($) by Countries (2015-2020)
Table Global Anti-Obesity Drugs Value Market Share by Regions (2015-2020)
Figure Global Anti-Obesity Drugs Value Market Share by Regions in 2019
Figure Global Anti-Obesity Drugs Production and Growth Rate (2015-2020)
Table Global Anti-Obesity Drugs Production by Major Countries (2015-2020)
Table Global Anti-Obesity Drugs Production Market Share by Major Countries (2015-2020)
Figure Global Anti-Obesity Drugs Production Market Share by Regions in 2019
Figure Global Anti-Obesity Drugs Consumption and Growth Rate (2015-2020)
Table Global Anti-Obesity Drugs Consumption by Regions (2015-2020)
Table Global Anti-Obesity Drugs Consumption Market Share by Regions (2015-2020)
Figure Global Anti-Obesity Drugs Consumption Market Share by Regions in 2019
Table Global Anti-Obesity Drugs Export Top 3 Country 2019
Table Global Anti-Obesity Drugs Import Top 3 Country 2019
Table United States Anti-Obesity Drugs Export and Import (2015-2020)
Table Europe Anti-Obesity Drugs Export and Import (2015-2020)
Table China Anti-Obesity Drugs Export and Import (2015-2020)
Table Japan Anti-Obesity Drugs Export and Import (2015-2020)
Table India Anti-Obesity Drugs Export and Import (2015-2020)
Table Global Anti-Obesity Drugs Production by Types (2015-2020)
Table Global Anti-Obesity Drugs Production Market Share by Types (2015-2020)
Figure Global Anti-Obesity Drugs Production Share by Type (2015-2020)
Table Global Anti-Obesity Drugs Value by Types (2015-2020)
Table Global Anti-Obesity Drugs Value Market Share by Types (2015-2020)
Figure Global Anti-Obesity Drugs Value Share by Type (2015-2020)
Figure Global Prescription Drugs Production and Growth Rate (2015-2020)
Figure Global Prescription Drugs Price (2015-2020)
Figure Global OTC Drugs Production and Growth Rate (2015-2020)
Figure Global OTC Drugs Price (2015-2020)
Table Global Anti-Obesity Drugs Consumption by Applications (2015-2020)
Table Global Anti-Obesity Drugs Consumption Market Share by Applications (2015-2020)
Figure Global Anti-Obesity Drugs Consumption Share by Application (2015-2020)
Figure Global Men Consumption and Growth Rate (2015-2020)
Figure Global Women Consumption and Growth Rate (2015-2020)
Figure North America Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Table North America Anti-Obesity Drugs Consumption by Countries (2015-2020)
Table North America Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure North America Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure United States Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Canada Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Mexico Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Table Europe Anti-Obesity Drugs Consumption by Countries (2015-2020)
Table Europe Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure Europe Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure Germany Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure France Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Italy Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Spain Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Anti-Obesity Drugs Consumption by Countries (2015-2020)
Table Asia-Pacific Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure China Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Japan Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure South Korea Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure India Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Anti-Obesity Drugs Consumption by Countries (2015-2020)
Table Middle East and Africa Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure UAE Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure South Africa Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure South America Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Table South America Anti-Obesity Drugs Consumption by Countries (2015-2020)
Table South America Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure South America Anti-Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure Brazil Anti-Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Table FlaxoSithKline plc Company Profile
Table FlaxoSithKline plc Production, Value, Price, Gross Margin 2015-2020
Figure FlaxoSithKline plc Production and Growth Rate
Figure FlaxoSithKline plc Value ($) Market Share 2015-2020
Table Norgine Pharmaceuticals Ltd. Company Profile
Table Norgine Pharmaceuticals Ltd. Production, Value, Price, Gross Margin 2015-2020
Figure Norgine Pharmaceuticals Ltd. Production and Growth Rate
Figure Norgine Pharmaceuticals Ltd. Value ($) Market Share 2015-2020
Table Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Production, Value, Price, Gross Margin 2015-2020
Figure Bristol-Myers Squibb Production and Growth Rate
Figure Bristol-Myers Squibb Value ($) Market Share 2015-2020
Table BoehringerIngelheim GmbH Company Profile
Table BoehringerIngelheim GmbH Production, Value, Price, Gross Margin 2015-2020
Figure BoehringerIngelheim GmbH Production and Growth Rate
Figure BoehringerIngelheim GmbH Value ($) Market Share 2015-2020
Table Orexigen Therapeutics Company Profile
Table Orexigen Therapeutics Production, Value, Price, Gross Margin 2015-2020
Figure Orexigen Therapeutics Production and Growth Rate
Figure Orexigen Therapeutics Value ($) Market Share 2015-2020
Table Eisai Co, Ltd. Company Profile
Table Eisai Co, Ltd. Production, Value, Price, Gross Margin 2015-2020
Figure Eisai Co, Ltd. Production and Growth Rate
Figure Eisai Co, Ltd. Value ($) Market Share 2015-2020
Table Takeda Pharmaceutical Company Profile
Table Takeda Pharmaceutical Production, Value, Price, Gross Margin 2015-2020
Figure Takeda Pharmaceutical Production and Growth Rate
Figure Takeda Pharmaceutical Value ($) Market Share 2015-2020
Table Novo Nordisk Company Profile
Table Novo Nordisk Production, Value, Price, Gross Margin 2015-2020
Figure Novo Nordisk Production and Growth Rate
Figure Novo Nordisk Value ($) Market Share 2015-2020
Table Alizyme Company Profile
Table Alizyme Production, Value, Price, Gross Margin 2015-2020
Figure Alizyme Production and Growth Rate
Figure Alizyme Value ($) Market Share 2015-2020
Table F. Hoffmann La Roche Company Profile
Table F. Hoffmann La Roche Production, Value, Price, Gross Margin 2015-2020
Figure F. Hoffmann La Roche Production and Growth Rate
Figure F. Hoffmann La Roche Value ($) Market Share 2015-2020
Table Rhythm Pharmaceuticals Company Profile
Table Rhythm Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Figure Rhythm Pharmaceuticals Production and Growth Rate
Figure Rhythm Pharmaceuticals Value ($) Market Share 2015-2020
Table Vivus Company Profile
Table Vivus Production, Value, Price, Gross Margin 2015-2020
Figure Vivus Production and Growth Rate
Figure Vivus Value ($) Market Share 2015-2020
Table Zafgen Company Profile
Table Zafgen Production, Value, Price, Gross Margin 2015-2020
Figure Zafgen Production and Growth Rate
Figure Zafgen Value ($) Market Share 2015-2020
Table GlaxoSmithKline Company Profile
Table GlaxoSmithKline Production, Value, Price, Gross Margin 2015-2020
Figure GlaxoSmithKline Production and Growth Rate
Figure GlaxoSmithKline Value ($) Market Share 2015-2020
Table Pfizer Company Profile
Table Pfizer Production, Value, Price, Gross Margin 2015-2020
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2015-2020
Table Shionogi USA Company Profile
Table Shionogi USA Production, Value, Price, Gross Margin 2015-2020
Figure Shionogi USA Production and Growth Rate
Figure Shionogi USA Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Production by Types (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Production Share by Types (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Value ($) by Types (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Value Share by Types (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Consumption by Applications (2020-2025)
Table Global Anti-Obesity Drugs Market Forecast Consumption Share by Applications (2020-2025)
